1. Home
  2. KLTR vs STTK Comparison

KLTR vs STTK Comparison

Compare KLTR & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kaltura Inc.

KLTR

Kaltura Inc.

HOLD

Current Price

$1.65

Market Cap

238.4M

Sector

Technology

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$3.05

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLTR
STTK
Founded
2006
2016
Country
United States
United States
Employees
563
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
238.4M
119.0M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
KLTR
STTK
Price
$1.65
$3.05
Analyst Decision
Strong Buy
Buy
Analyst Count
2
5
Target Price
$3.50
$4.00
AVG Volume (30 Days)
360.8K
392.9K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$180,921,000.00
$1,000,000.00
Revenue This Year
$3.10
N/A
Revenue Next Year
$1.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.88
N/A
52 Week Low
$1.36
$0.69
52 Week High
$2.82
$3.38

Technical Indicators

Market Signals
Indicator
KLTR
STTK
Relative Strength Index (RSI) 53.00 67.21
Support Level $1.59 $2.82
Resistance Level $1.71 $3.30
Average True Range (ATR) 0.10 0.24
MACD 0.01 -0.00
Stochastic Oscillator 58.57 74.76

Price Performance

Historical Comparison
KLTR
STTK

About KLTR Kaltura Inc.

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: